| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.005 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.005 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.13 | 0.006 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.006 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.087 | 0.006 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.009 |